Join to View Full Profile
NIH clinical center, 10 Center Dr, Room 3B38Bethesda, MD 20892
Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Certifications & Licensure
- MD State Medical License 2023 - 2026
- OR State Medical License 2019 - 2020
Publications & Presentations
PubMed
- The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.Rahul Lakhotia, Christopher Melani, Stefania Pittaluga, Max J Gordon, James D Phelan
British Journal of Haematology. 2025-06-16 - A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies.Max J Gordon, Sigrid Dubois, Milos D Miljkovic, Samuel Ng, Bonita Bryant
Blood Neoplasia. 2025-02-01 - 1 citationsA phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.Max J Gordon, Sigrid Dubois, Bonita Bryant, Samuel Ng, Kevin Conlon
Leukemia & Lymphoma. 2024-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: